APAC OTC Sleep Aid Products Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : February 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5048

  • Format: PPT, PDF

APAC OTC Sleep Aid Products Market Analysis: Segmented by Sleeping Disorders, Product, Medication and Country – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2026

Clear
SKU: 5048 Categories: ,

Report Description of the OTC Sleep Aid Products  Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for OTC Sleep Aid Products Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the OTC Sleep Aid Products market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

APAC OTC Sleep Aid Products Market Executive Summary

Asia-Pacific sleep disorder treatment market is expected to grow due the increased prevalence of sleep disorders like sleep apnea, insomnia and narcolepsy across globe. Sleep disorders are also known as somnipathy. It comprises of various medical conditions which deviates the sleeping pattern of a person negatively. Sleep disorders can also be defined as a group of disorders impacting sleep pattern of an individual on a regular basis. Various factors are responsible for the presence of sleep disorders which includes lifestyle changes and high stress among other. The sleep disorders impact the overall health of a person along with affecting their level of concentration leading to tiredness throughout the day.

Market Size and Key Findings

The APAC OTC Sleep Aid Products market size stood at around USD 11.95 billion in 2021 and is projected to reach USD 16.68 billion by 2026, exhibiting a CAGR of 6.9% during the forecast period.

APAC OTC Sleep Aid Products market is likely to grow at remarkable rate during the forecast period. Sleep aids are primary pills and medical devices enabling a person affected with sleep disorders to fall asleep. Sleep Aids are drugs or medical devices that help a person to fall asleep. Improper sleep cycles or sleep disorders have severe effects on one’s work life and health. Sleep Disorders are generally caused by changes in sleeping patterns due to medical issues, psychiatric problems, and environmental issues.

Market Dynamics

Market Growth Drivers Analysis

The increased usage of caffeine, tobacco, and alcohol has been causing sleep disorders in the population is one of the major factors driving the Asia-Pacific sleep aids market. The increasing consumer awareness pertaining to quality sleep, rising size of the geriatric population will act as substantial factors for the industry expansion has led to the growing need for convenience and compliance. Further, an increase in demand for sleeping pills due to stressful modern lifestyle has also contributed to the rapid growth of the Asia-Pacific Sleep Aids market.

Market Restraints

The sleep aids market also faces some challenges and restraints, including side effects associated with sleeping aids medications and patent expiration of treatment pills for sleep disorders.

COVID-19 impact on “APAC OTC Sleep Aid Products Market” 

The COVID-19 pandemic took a tremendous toll on the operations of several business verticals. However, the industry for sleep aids witnessed widespread growth given the increasing consumption of sleep medications by patients affected with sleep-disordered breathing (SDB) as they are at a higher risk of suffering from the most adverse outcomes of the infection. The rising innovations in sleep medicine practices also added to the market demand amidst the crisis

Competitive Landscape

Key Players

Some of the major key players dominating the Asia Pacific Sleep Aids market are Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Amneal Pharmaceuticals LLC, Taj Pharmaceuticals Limited, Eli Lilly and Company, Alembic Pharmaceuticals Limited, Apotex Inc., Dr. Reddy’s Laboratories Ltd., Koninklijke Philips N.V., ResMed, SomnoMed, Oventus and BMC Medical Co., among others.

Products in Pipeline

TS 142 is dual orexin 1/2 receptor antagonist (DORA), being developed by Taisho Pharmaceutical, for the treatment of insomnia and sleep apnoea syndrome.

Daridorexant is a dual orexin receptor antagonist (DORA) designed and developed for the treatment of insomnia. Daridorexant reduces overactive wakefulness associated with insomnia by blocking the activity of orexin. Idorsia’s research team has designed daridorexant to have a rapid onset of effect and a duration of action sufficient to cover the night but short enough to avoid any negative next-morning residual activity at optimally effective doses. The US Food and Drug Administration (FDA) has accepted the new drug application (NDA) for review of Idorsia’s investigational dual orexin receptor antagonist, daridorexant, for the treatment of adult patients with insomnia.

Notable Recent Deals

Pfizer, Inc. announced that its division named Upjohn is combined with Mylan N.V. and formed a new company named Viatris. This combination of the business division of the company with Mylan N.V. has increased its product portfolio leading to increased demand for its product in the market.

This new product launched by the company has increased its protein estimation portfolio in the market. Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the sleep disorder treatment market which also provides the benefit for organization to improve their offering for sleep disorder treatment market.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

China’s stringent regulatory framework, specifically regarding product registration (under China’s Food and Drug Administration – CFDA), and competition from cheap local brands are considerable challenges.

 

 

1. Report Description of the APAC OTC Sleep Aid Products Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC OTC Sleep Aid Products Market Executive Summary
2.1 APAC OTC Sleep Aid products market- Industry Snapshot & key buying criteria, 2020-2026
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC OTC Sleep Aid Products market
3.1 Market Growth Drivers Analysis
3.1.1 Increased Use of Caffeine, Tobacco and Alcohol
3.1.2 Raising Geriatric Population
3.1.3 Raising consumer awareness pertaining to quality sleep
3.1.4 Increase demand for sleeping pills
3.2 Market Restraints Analysis
3.2.1 Side effects associated with sleeping aid medications
3.2.2 Patent expiration of treatment pills for sleeping disorder
3.3 Covid-19 Market Impact Analysis
3.3.1 Positive impact on outcomes
4. OTC Sleep Aid Products Market Segmentation
4.1 By Sleeping Disorder Type:
4.1.1 Insomnia
4.1.2 Sleep Apnea
4.1.3 Restless Legs Syndrome
4.1.4 Narcolepsy
4.1.5 Sleepwalking
4.2 By Product Type:
4.2.1 Mattresses and Pillows
4.2.2 Sleep Laboratories
4.2.3 Medications
4.2.4 Sleep Apnea Devices
4.3 By Medication Type:
4.3.1 Prescription based Drugs
4.3.2 OTC Drugs
4.3.3 Herbal Drugs
4.4 By Country:
4.4.1 India
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Australia
4.4.6 New Zealand
4.4.7 Thailand
4.4.8 Malaysia
4.4.9 Vietnam
4.4.10 Philippines
4.4.11 Indonesia
4.4.12 Singapore
4.4.13 Rest of APAC
5. OTC Sleep Aid Products Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Substance Abuse Drugs Market
6.4 Notable recent deals in Substance Abuse Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Jazz Pharmaceuticals, Inc. Company overview
Product & Services, Strategies & Financials
7.2 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.3 Viatris Inc. Company overview
Product & Services, Strategies & Financials
7.4 Amneal Pharmaceuticals LLC Company overview
Product & Services, Strategies & Financials
7.5 Taj Pharmaceuticals Limited Company overview
Product & Services, Strategies & Financials
7.6 Eli Lilly and Company
Product & Services, Strategies & Financials
7.7 Alembic Pharmaceuticals Limited Company overview
Product & Services, Strategies & Financials
7.8 Apotex Inc. Company overview
Product & Services, Strategies & Financials
7.9 Dr. Reddy’s Laboratories Ltd. Healthcare
Product & Services, Strategies & Financials
7.10 Koninklijke Philips N.V.
Product & Services, Strategies & Financials
7.11 ResMed Company overview
Product & Services, Strategies & Financials
7.12 SomnoMed Company overview
Product & Services, Strategies & Financials
7.13 Oventus Company overview
Product & Services, Strategies & Financials
7.14 BMC Medical. Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of OTC Sleep Aid Products market
9.2 Future Opportunities
10. Strategic Recommendations

OTC Sleep Aid Products Market Segmentation

By Sleep Disorder Type:

Based on sleep disorder, the sleep aids market is segmented under Insomnia, Sleep Apnea, Narcolepsy, Restless legs syndrome, and Sleepwalking. Sleep apnea remains to be the fastest-growing segment compared to other sleep disorders

  • Insomnia
  • Sleep Apnea
  • Restless legs Syndrome
  • Narcolepsy
  • Sleep Walking

By Product Type:

The Asia-Pacific Sleep Aids market is segmented into Sleep Laboratories, Mattresses & Pillows, Medication, and Sleep apnea devices by product. Mattresses and pillows are expected to continue leading the Asia-Pacific Sleep Aids market in coming years

  • Mattresses and Pillows
  • Sleep Laboratories
  • Medications
  • Sleep Apnea Devices

By Medication Type:

Based on Medication types, the segmentation is done under Prescription-based Drugs, OTC drugs, and Herbal Drugs. The prescription medications hold the largest share in the Sleep Aids market

  • Prescription based Drugs
  • OTC Drugs
  • Herbal Drugs

By Country Type:

The Asia-Pacific Sleep Aids market is segmented under various countries, namely China, India, Japan, Australia, and South Korea

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements